JOINT FILING AGREEMENT
EXHIBIT 99.1
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that this Statement on Schedule 13D relating to the Common Stock, $0.001 par value, of Synageva Biopharma Corp. is being filed with the Securities and Exchange Commission on behalf of each of them.
July 19, 2012
XXXXX BROS. ADVISORS, LLC | ||
By: | /s/ Xxxxx X. Xxxxxxx | |
Name: Xxxxx X. Xxxxxxx | ||
Title: President | ||
By: | /s/ Xxxxxx X. Xxxxx | |
Xxxxxx X. Xxxxx | ||
By: | /s/ Xxxxx X. Xxxxx | |
Xxxxx X. Xxxxx | ||
FBB Associates | ||
By: | /s/ Xxxxxx X. Xxxxx | |
Name: Xxxxxx X. Xxxxx | ||
Title: Partner |
[AG NOTE: DELETE THIS BLANK PAGE]